Infections of Gastrointestinal Tract
Infections of Gastrointestinal Tract
Infections of Gastrointestinal Tract
LEARNING OUTCOMES
At the end of the chapter, students must have:
1. Recognized common gastrointes nal tract infec ons based on clinical manifesta ons;
2. Di eren ated invasive from non-invasive diarrhea;
3. Compared the ve hepa c infec ons;
4. Described the characteris cs of the causa ve organisms of each gastrointes nal tract
infec on;
5. Explained how the di erent gastrointes nal tract infec ons are transmi ed; and
6. Discussed the appropriate laboratory diagnosis, treatment, and preven on of each
infec on.
WARM-UP ACTIVITY
What is your POOP telling you?
Poop does a lot more than just get your waste out of your body! If you aren’t aware, your
poop is actually a good indicator of your health in a lot of ways. The Bristol stool chart
iden es seven di erent shapes of human feces and is used to medically diagnose a person
based on the shape of the stool of that person. Using this scale is a good way to di eren ate
between what a healthy stool should look like and what other shapes might mean.
ff
ti
ti
ti
fi
ti
fi
ff
ff
ti
ti
ti
ti
ti
ft
ti
ti
ti
ff
ti
ti
ti
ti
ti
ti
ti
ti
tt
ti
ti
ti
ff
tt
ti
ti
ti
Uh-oh, you might need some help if
thie con nues. No good, best to get Mum or Dad
ti
fl
fi
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
fl
ti
ti
fl
fl
fl
ti
fl
ti
ti
ti
ti
ti
ti
ti
fl
fl
ti
ti
ti
ti
ti
fl
ti
ft
ti
ti
ti
fl
ti
ti
ff
ti
ti
ti
fl
ti
ti
ti
prevention: Sucrose
xx
-Floss
-brushing, visiting
dentist every 6
and this breaks down the enamel of the teeth, leading to localized
months
flouride, so ening of the external enamel.
mouthwash(clorhexibi b. Ac nomyces
n) c. Lactobacilli
2. Periodental Disease - a term used to describe condi ons taht are characterized by
in amma on and degenera on of structures that support the teeth.
a. Gingivi s - the reversible in amma on of the gums, characterized by bleeding
of the gums while brushing the teeth.
• E ologic agents:
a. Streptococci
b. Ac nomyces
c. Anaerobic gram-nega ve bacteria (Prevotella, Bacteroides, and
Fusobacterium nucleatum)
b. Periodon s - a chronic gum disease that can cause bone destruc on and tooth
loss. It generally causes li le discomfort.
c. Acute Necro zing Ulcera ve Gingivi s (Vincent’s Disease/Trench Mouth) -
characterized by pain that prevents normal chewing and may be accompanied
by bad breath or halitosis.
• E ologic agent: Prevotella intermedia
• Treatment and Preven on:
a. Adequate debridement
b. Oxidizing agents
c. Miconazole
3. Oral Thrush- characterized by white patches adherent to the oral mucosa and may
occur on the tongue, lips, gums, or palate. overgrowth- thrush
• E logic agent: Candida albicans - a fungus that is part of the normal ora of the
skin, mucous membranes, and gastrointes nal tract.
• Predisposing Factors:
a. Endocrine disturbances pregnant
b. Prolonged intake of an bio cs
c. Malnutri on
d. Malignancy
e. Immunocompromised
f. Prolonged use of steroids
• Laboratory Diagnosis: examina on of scraped material under the microscope
demonstra ng the characteris cs of pseudohyphae
• Treatment and Preven on:
a. Nysta n - DOC
b. Correc ng the predisposing factors
c. Avoiding unnecessary use of an bio cs
4. Mumps (Epdemic Paro s) - a highly communicable disease characterized by painful
in amma on of the salivary glands. parotive glands
• E logic agent: Mumps virus - a member of the family Paramyxoviridae.
• Mode of Transmission: respiratory droplets
• Clinical Findings: The virus infects the salivary glands, the paro d glands
predominantly infected. A er incuba on period of 18-21 days, the pa ent
unilateral or bilateral.
Angelica May DC. Mendoza, RPh, MS Page 3 of 12
ti
ti
ti
ti
fl
fl
ft
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
tt
ti
ti
ft
ti
fl
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
fl
ti
ti
develops fever, malaise, anorexia followed by tender swelling of the paro d
glands and/or salivary glands. Involvement can be unilateral or bilateral.
• Complica ons:
a. Orchi s - in amma on of the testes
b. Meningi s coverings of the brain
• Laboratory Diagnosis: based on clinical manifesta ons. Virus isola on from
saliva, spinal uis, or urine can be done. Measurement of an body ters can
also be made.
• Treatment and Preven on:
a. Treatment is mainly suppor ve
b. MMR vaccine - preven on
Stomach
1. Gastri s and Pep c Ulcer Disease
• E logic agent: Helicobacter pylori - it has 2 major virulence factors: rapid
mo lity and urease produc on.
• Mode of Transmission: acquired through inges on and person-to -person
transmission may also occur.
• Clinical Findings: characterized by recurrent pain in the upper abdomen,
especially around the epigastric area. This may be complicated by bleeding into
the GIT.
• Laboratory Diagnosis: gastric biopsy specimen can be used for histologic
examina on. Culture can also be done as well as measurement of an body
levels speci c for H. pylori.
• Treatment and Preven on: triple therapy with proton pump inhibitor, -razol
-mycin macrolide, and amoxicillin for 7 to 10 days. omeprazol,
clarithromycin
Liver
1. Hepa s - in amma on of the liver is termed hepa s.
• E ologic agents:
a. Hepa s viruses - most important cause
b. Other viruses - Cytomegalovirus, Epstein Barr virus, Herpes Simplex virus,
Rubella virus, Enteroviruses, Dengue virus, and the Yellow Fever virus.
• Clinical Findings: the same, regardless of which hepa s virus is the cause. Typical
signs and symptoms include fever, anorexia, nausea, vomi ng, and jaundice. Dark
urine and pale feces are also observed. Most cases resolved sponatneously in 1 to
4 weeks.
ti
ti
ti
ti
ti
ti
ti
fi
fl
fl
fl
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
Table 1. Comparison of Features of Hepa s Viruses
Feature Hepa sA Hepa sB Hepa sC Hepa sD Hepa sE
Common “Infec ous” “Serum” “Non-A, Non- “Delta agent” “Enteric non-
Name
street foods
B post- defective A, non-B)
transfusion” virus
Virus Picornavirus; Hepadnavirus Flavivirus; Viroid-like; Hepevirus;
Structure capsid RNA ; envelope, envelope, envelope, Calcivirus-like
DNA RNA circular DNA capsid
Transmission Fecal-oral Parenteral, Parenteral, Parental, Fecal-oral
sexual, sexual, sexual
insidous insidous
Incuba on 15-50 45-160 140-180+ 15-64 15-50
Period (Days)
Severity Mild Occasionally Usually sub- Co-infec on Normal
severe clinical; 70% or super pa ents,
chronicity infec on with mild;
subclinical HBV pregnant
women,
severe
Carrier State No Yes Yes Yes No
ti
ti
ti
ti
Small and Large Intes nes
1. Gastroenteri s (Diarrhea) - a change in the normal bowel habits of an individual, with
an increase in the frequency, idity, looseness, and volume of feces excreted per day
in comparison to the usual fecal output of the individual.
• Mode of Transmission: Fecal-oral transmission small intestines, no blood but
• Clinical Findings: watery
a. Non- invasive - result of disrup on of the secretory process due to the
toxin released from the bacteria. This is characterized by watery diarrhea
and the absence of blood or leukocytes in the feces.
b. Invasive - there is direct damage to the GIT ssues due to direct invasion
by the bacteria. It is characterized by fever, dysentery (blood in stools),
and leukocytes in the feces. large intestines, bloody
• E ologic Agents:
a. Escherichia coli - a gram-nega ve, mo le, encapsulated rod that is a
four virolence member of the family Enterobacteriaceae and is a member of the normal
intes nal ora.
‣ Five Pathogenic Groups
i. Enterotoxigenic E. coli (ETEC) - major cause of “traveler’s
diarrhea” or “turista” and is an imporatnt cause of diarrhea in
infants in developing coun es. Produces cholera-like toxin,
non-invasive.
ii. Enteropathogenic E. coli (EPEC) - important cause of diarrhea
in infants in developing countries. The organism adheres to
mucosal cells of the small intes ne and causes loss of
microvilli. This leads to watery diarrhea.
iii. Enteroaggrega ve/Adheren E. coli (EAEC) - causes acute and
chronic diarrhea. Produces ST-like toxin and a hemolysin.
iv. Enterohemorrhagic E. coli (EHEC) - Prodces a shiga-like toxin
shigella as that produced by Shigella. It is a verotoxin that is cytotoxic,
disenterae?? neurotoxic, and enterotoxic. It is associated with hemorrhagic
coli s. In 2011, E. coli O104:H4 caused a serious outbreak of
food borne illness in Germany.
v. Enteroinvasive E. coli (EIEC) - causes invasion of the colonic
mucosa. The disease is characterized by acute bloody diarrhea
with malaise, headache, high fever, and abdominal pain. It is
the most common cause of UTI as well as meningi s in
newborns.
• Laboratory Diagnosis: culture of organism using a di eren al
medium (EMB or MacConkey’s agar)
• Treatment and Preven on:
i. Trimethoprim + Sulfamethoxazole - given to shorten
symptoms and eliminate invasive forms
ii. Fluid and electrolyte replacement
iii. D o x y c y c l i n e , C i p r o o x a c i n , o r Tr i m e t h o p r i m +
Sulfamethoxazole - prophylaxis for Traveler’s diarrhea
ti
ti
ti
ti
fl
ti
fl
ti
ti
ti
ti
ti
ti
ff
ti
b. Salmonella spp- gram-nega ve, encapsulated, mo le rods that also
belongs to the family Enterobacteriaceae. The organism has 3 important
an gens - cell wall (soma c) O, agellar H, and capsular Vi (virulence)
an gens.
• Two Categories:
i. Typhoidal species - S. typhi and S. paratyphi
ii. Non-typhoidal species - S. enteri dis and S. cholerasuis)
**S. cholerasuis is most commonly involved in systemic
infec on.
• Clinical Findings:
iii. Enterocoli s - characterized by invasion of the small and large
instes ne. It begins with nausea and vomi ng which
progresses to abdominal pain and diarrhea. S. enteri dis
serotype typhimurium is the most common cause.
iv. Typhoid or Enteric fever - begins in the small intes nes but
gallblader few gastrointes nal symptoms occur. Survival and growth of
the organism in phagocy c cells is a striking feature of this
disease as well as the predilec on to invade the gallbladder,
resul ng in the establishment of a carrier state - asymptoma c
carriage of the bacteria for more than 1 year. It is commonly
caused by S. typhi but can also be caused by S. paratyphi.
v. Sep cemia - occurs in two se ngs: a pa ent with underlying
infection in the disease or acancer, or a child with enterocoli s. This is most
blood commonly caused by S. cholerasuis. Symptoms begin with
fever with li le or no enterocoli s then proceed to focal
symptoms. Osteomyeli s, pneumonia, and meningi s are the
most common sequelae.
• Laboratory Diagnosis:
i. Enterocoli s - stool exam, stool smear and stool culture
ii. Typhoid fever - organism isola on and biochemical test widal test
• Treatment and Preven on:
i. Ampicillin
ii. Trimethoprim-Sulfamethoxazole
iii. 3rd genera on cephalosporins
iv. Surgical removal of the gallbladder
v. Vaccines - preven on
c. Shigella spp- gram-nega ve, non-mo le rods which are members of the
family Enterobacteriaceae.
• Species:
i. S. sonnei
ii. S. exneri
iii. S. boydii
iv. S. dysenteriae type I (Shiga bacillus) - the most clinically
signi cant as it is responsible for epidemics with high
mortality. The major virulence factor is the Shiga toxin.
puss i the poop with fever
ti
ti
ti
tt
ti
ti
ti
ti
ti
ti
ti
ti
ti
tti
ti
ti
fl
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
Clinical Findings: characterized by lower abdominal pain, fever, and •
bloody, mucoid diarrhea. Bowel movement is accompanied by
tenesmus or strained defeca on. A carrier state may also occur.
• Complica ons:
i. Perfora on of the colon
ii. Hemoly c-uremic syndrome
iii. Ekiri syndrome
• Laboratory Diagnosis:
i. Stool examina on revealing leukocytes and/or RBC in fresh
stool specimen
ii. Culture of feces
• Treatment and Preven on:
i. Cipro oxacin
ii. Ampicillin
iii. Doxycycline
iv. Trimethoprim-Sulfamethoxazole
d. Yersinia enterocoli ca- also a member of the family Enterobacteriaceae
meat and dairy and are gram-nega ve, urease-posi ve rods.
producs, contaminated • Clinical Findings: the organism causes in amma on and ulcera on
water by domestics in the ssues a ected. Early symptoms include fever, abdominal
animals pain, and diarrhea that is watery to bloody.
• Laboratory Diagnosis: Culture of feces - grow best with “cold
enrichment” or at low temperature of 4oC.
e. Vibrio cholerae- serogroups O1 and O139 cause cholera epidemics.
• Clinical Findings: Cholera - there is sudden onset of nausea and
pathogenic vomi ng, and profuse watery diarrhea (as much as a 20-30L/day)
only to with abdominal cramps. The stools may resemble “rice water”.
humans
There is severe dehydra on which can lead to circulatory collapse
and hypovolemic shock may result in death if the pa ent is not
treated promptly.
• Laboratory Diagnosis: Typical clinical presenta on. Microscopic
examina on using dark eld or phase contrast microscopy. Culture is
also diagnos c.
• Treatment and Preven on:
i. Rapid uid and electrolyte replacement
ii. Tetracycline - DOC
f. Clostridium perfringens- a toxin producing organism that can produce
invasive infec on. It produces numerous toxins and enzymes that result in
spreading infec on.
• Clinical Findings: Enteri s necro cans - an acute necro zing process
in the small intes nes that manifests with abdominal pain and
bloody diarrhea.
• Laboratory Diagnosis: culture under anaerobic condi ons.
• Treatment and Preven on:
i. Penicillin - DOC
ii. An toxins in the form of immune globulins
ti
ti
ti
ti
ff
ti
ti
ti
ti
ti
ti
fi
ti
ti
ti
ti
ti
fl
ti
ti
ti
ti
ti
ti
ti
fl
ti
ti
ti
ffi
ti
ti
ti
fi
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ff
ti
ti
ti
ti
ti
ti
ti
ti
ti
fi
ti
fi
ti
ti
ti
ff
ti
ft
ti
ti
fl
ti
ti
fi
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ti
ft
ti
ti
ti
Ac vity 1
You are expected to par cipate in the online lecture on December 22, 2020
(Tuesday; 8am-8:30am for Level IIA and 9am-9:30am for Level IIB).
Ac vity 2
You are expected to par cipate in the online lecture on December 22, 2020
(Tuesday; 8:30am-9:00am for Level IIA and 9:30am-10:00am for Level IIB).
WRAP-UP ACTIVITY
Summarize what you have learned or how your new learnings has changed your
thoughts on the topic.
POST-ASSESSMENT
Worksheet 14 (Lecture)
You are required to accomplish the Worksheet 14. The ac vity will be posted on
December 21, 2020 (Monday) in the mVLE course page. Make sure to complete and submit
your output on or before 11:59 pm December 27, 2020 (Sunday).
Worksheet 14 (Laboratory)
You are required to accomplish the Worksheet 14. The ac vity will be posted on
December 21, 2020 (Monday) in the mVLE course page. Make sure to complete and submit
your output on or before 11:59 pm December 27, 2020 (Sunday).
Quiz 14
You are required to take the Quiz 14. The quiz will be posted on December 22,
2020(Tuesday) a er the online lecture in the mVLE course page. Make sure to complete and
submit your output on or before 11:59 pm December 22, 2020 (Tuesday).
ft
ti
ti
ti
ti
ti
ti
fl
fl
ti
ti
ti
ti
ti
ti
ti